Daily administration ofm-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects
- 1 June 1996
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 127 (1) , 140-149
- https://doi.org/10.1007/bf02805987
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- In vivo properties of SB 200646A, a 5‐HT2C/2B receptor antagonistBritish Journal of Pharmacology, 1994
- Effects of Clozapine and Fluphenazine Treatment on Responses to m-Chlorophenylpiperazine Infusions in SchizophreniaArchives of General Psychiatry, 1993
- The effects of 5‐HT and m‐chlorophenylpiperazine (m‐CPP) on the efflux of [3H]‐5‐HT from human perfused platelets.British Journal of Clinical Pharmacology, 1993
- Behavioural evidence for functional interactions between 5‐HT‐receptor subtypes in rats and miceBritish Journal of Pharmacology, 1990
- Hyperresponsivity to the Serotonin Agonist m-Chlorophenylpiperazine in Alzheimer's DiseaseArchives of General Psychiatry, 1989
- Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- Serotonergic Responsivity in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1988
- Serotonergic Responsivity in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1987
- 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazoleJournal of Pharmacy and Pharmacology, 1982
- The role of norfenfluramine in fenfluramine-induced mydriasisJournal of Pharmacy and Pharmacology, 1973